Re: Sounds Like Good News ??
So maybe it will end up that the standard of care for adjuvant therapy of HER2+ will be a low dose chemo with herceptin AND tykerb. I just wish there was a way we could know if we were one of the 30%who showed resistance to herceptin, so tykerb could be added from the start. SIGH. . . I don't like knowing that that many HER2+ tumors are resistant.
__________________
Diagnosed 7/09 with 7mm IDC ER weakly +, PR -, Her2+
TCH chemo 8/09-12/09
Ooph/hysterectomy 4/10
Started Femara 6/10
Completed year of herceptin 10/11
Zometa 1/11 (2X/yr for 2yrs)
Hopefully nothing else!!!!
|